Low-Dose Sulfamethoxazole-Trimethoprim Could Prevent Pneumocystis jiroveci Pneumonia in Kidney Transplant Recipients: A Retrospective, Observational Study
An adequate prophylactic duration of either quarter-strength daily TMP-SMX or half-single strength daily TMP-SMX may protect kidney transplant recipients from PJP.
Authors
- Kuifen Ma (ORCID: https://orcid.org/0000-0001-8547-4325)
- Jianyong Wu (ORCID: https://orcid.org/0000-0002-4587-2529)
- Chunchun Wei (ORCID: https://orcid.org/0000-0002-1450-3050)
- Rongrong Wang (ORCID: https://orcid.org/0000-0002-4733-8274)
- Xiuhua Wu
- Xishao Xie
Institutions
- Affiliated Hangzhou First People's Hospital, Westlake University, School of Medicine (CN)
- First Affiliated Hospital Zhejiang University (CN)
Publication Details
- Journal
- Therapeutics and Clinical Risk Management
- Published
- 2025-09-01
- DOI
- https://doi.org/10.2147/tcrm.s528627
- Primary Topic
- Pneumocystis jirovecii pneumonia detection and treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00